New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar.

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...

How GLP-1 therapies could help build a healthier, more productive workforce—and what that would mean for how we live together ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.

Most of Asia's major rivers find their source on the Tibetan plateau. However as the global temperature rises, Tibet’s glaciers are melting and grassland permafrost is thawing at an alarming rate.

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, manufactured by Novo Nordisk. Reuters Eli Lilly said Wednesday that its obesity drug Zepbound ...